SETD2 and leukemia: For instance, in leukemia where alteration of SETD2 induces a resistance to chemotherapy, treatment with JIB-04, an inhibitor of the H3K9/36me3 demethylase KDM4A, restored H3K36me3 levels and chemotherapy sensitivity in vitro and in vivo [104].